Literature DB >> 20133716

ATP-independent CFTR channel gating and allosteric modulation by phosphorylation.

Wei Wang1, Jianping Wu, Karen Bernard, Ge Li, Guangyu Wang, Mark O Bevensee, Kevin L Kirk.   

Abstract

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) channel, an ATP binding cassette (ABC) transporter. CFTR gating is linked to ATP binding and dimerization of its two nucleotide binding domains (NBDs). Channel activation also requires phosphorylation of the R domain by poorly understood mechanisms. Unlike conventional ligand-gated channels, CFTR is an ATPase for which ligand (ATP) release typically involves nucleotide hydrolysis. The extent to which CFTR gating conforms to classic allosteric schemes of ligand activation is unclear. Here, we describe point mutations in the CFTR cytosolic loops that markedly increase ATP-independent (constitutive) channel activity. This finding is consistent with an allosteric gating mechanism in which ligand shifts the equilibrium between inactive and active states but is not essential for channel opening. Constitutive mutations mapped to the putative symmetry axis of CFTR based on the crystal structures of related ABC transporters, a common theme for activating mutations in ligand-gated channels. Furthermore, the ATP sensitivity of channel activation was strongly enhanced by these constitutive mutations, as predicted for an allosteric mechanism (reciprocity between protein activation and ligand occupancy). Introducing constitutive mutations into CFTR channels that cannot open in response to ATP (i.e., the G551D CF mutant and an NBD2-deletion mutant) substantially rescued their activities. Importantly, constitutive mutants that opened without ATP or NBD2 still required R domain phosphorylation for optimal activity. Our results confirm that (i) CFTR gating exhibits features of protein allostery that are shared with conventional ligand-gated channels and (ii) the R domain modulates CFTR activity independent of ATP-induced NBD dimerization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133716      PMCID: PMC2840504          DOI: 10.1073/pnas.0913001107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Structure of a bacterial multidrug ABC transporter.

Authors:  Roger J P Dawson; Kaspar P Locher
Journal:  Nature       Date:  2006-08-30       Impact factor: 49.962

2.  Flexibility in the ABC transporter MsbA: Alternating access with a twist.

Authors:  Andrew Ward; Christopher L Reyes; Jodie Yu; Christopher B Roth; Geoffrey Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

3.  Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains.

Authors:  Wei Wang; Karen Bernard; Ge Li; Kevin L Kirk
Journal:  J Biol Chem       Date:  2006-12-18       Impact factor: 5.157

4.  Structural basis of trans-inhibition in a molybdate/tungstate ABC transporter.

Authors:  Sabina Gerber; Mireia Comellas-Bigler; Birke A Goetz; Kaspar P Locher
Journal:  Science       Date:  2008-05-29       Impact factor: 47.728

5.  Activating cystic fibrosis transmembrane conductance regulator channels with pore blocker analogs.

Authors:  Wei Wang; Ge Li; John Paul Clancy; Kevin L Kirk
Journal:  J Biol Chem       Date:  2005-04-27       Impact factor: 5.157

6.  Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein.

Authors:  Ying Wang; Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2007-10-02       Impact factor: 5.157

7.  CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices.

Authors:  Jennifer M R Baker; Rhea P Hudson; Voula Kanelis; Wing-Yiu Choy; Patrick H Thibodeau; Philip J Thomas; Julie D Forman-Kay
Journal:  Nat Struct Mol Biol       Date:  2007-07-29       Impact factor: 15.369

8.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

9.  The intact CFTR protein mediates ATPase rather than adenylate kinase activity.

Authors:  Mohabir Ramjeesingh; Francisca Ugwu; Fiona L L Stratford; Ling-Jun Huan; Canhui Li; Christine E Bear
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

10.  G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.

Authors:  Silvia G Bompadre; Yoshiro Sohma; Min Li; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2007-03-12       Impact factor: 4.086

View more
  38 in total

1.  Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels.

Authors:  Shipeng Wei; Bryan C Roessler; Mert Icyuz; Sylvain Chauvet; Binli Tao; John L Hartman; Kevin L Kirk
Journal:  FASEB J       Date:  2015-11-25       Impact factor: 5.191

Review 2.  Mechanistic insight into the heme-independent interplay between iron and carbon monoxide in CFTR and Slo1 BKCa channels.

Authors:  Guangyu Wang
Journal:  Metallomics       Date:  2017-05-05       Impact factor: 4.526

3.  Converting nonhydrolyzable nucleotides to strong cystic fibrosis transmembrane conductance regulator (CFTR) agonists by gain of function (GOF) mutations.

Authors:  George Okeyo; Wei Wang; Shipeng Wei; Kevin L Kirk
Journal:  J Biol Chem       Date:  2013-04-25       Impact factor: 5.157

4.  The inhibition mechanism of non-phosphorylated Ser768 in the regulatory domain of cystic fibrosis transmembrane conductance regulator.

Authors:  Guangyu Wang
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

5.  Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modifications.

Authors:  Michelle McClure; Lawrence J DeLucas; Landon Wilson; Marjorie Ray; Steven M Rowe; Xiaoyun Wu; Qun Dai; Jeong S Hong; Eric J Sorscher; John C Kappes; Stephen Barnes
Journal:  Protein Eng Des Sel       Date:  2011-11-25       Impact factor: 1.650

Review 6.  Nonequilibrium gating of CFTR on an equilibrium theme.

Authors:  Kang-Yang Jih; Tzyh-Chang Hwang
Journal:  Physiology (Bethesda)       Date:  2012-12

Review 7.  Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability.

Authors:  P Andrew Chong; Pradeep Kota; Nikolay V Dokholyan; Julie D Forman-Kay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

8.  Regulation of activation and processing of the cystic fibrosis transmembrane conductance regulator (CFTR) by a complex electrostatic interaction between the regulatory domain and cytoplasmic loop 3.

Authors:  Guangyu Wang; Dayue Darrel Duan
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

Review 9.  Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications.

Authors:  Yoshiro Sohma; Ying-Chun Yu; Tzyh-Chang Hwang
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  The CFTR ion channel: gating, regulation, and anion permeation.

Authors:  Tzyh-Chang Hwang; Kevin L Kirk
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.